DJ Biogen Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slid 3.25% to $214.35 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.87% to 7,641.16 and Dow Jones Industrial Average falling 1.32% to 52,759.21.
The stock's fall snapped a two-day winning streak.
Biogen Inc. closed 3.51% short of its 52-week high of $222.15, which the company achieved on August 19th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 2.21% to $267.37, Pfizer Inc. $(PFE)$ fell 1.59% to $27.79, and AbbVie Inc. $(ABBV)$ fell 1.56% to $261.83.
Trading volume (808,371) remained 414,428 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.